Archive for October 2020
Mass. Life Sciences Center looks to Massport for its new CEO
The board of the directors for Massachusetts Life Sciences Center has offered the president and CEO job to Kenneth Turner, a longtime Massachusetts Port Authority executive and a U.S. Navy veteran. Read More
Read MoreMLB teams’ ticket strategy: Plan for 2021, hope for ‘2019’
How will Major League Baseball teams plan for selling tickets for 2021? Read More
Read MoreChamber strikes partnership with Boston While Black
The membership group, launched this summer, is striving to make the city a more attractive place for Black professionals and graduate students. Read More
Read MoreBoston officials consider further restricting indoor, outdoor gatherings
The city is focused on minimizing the danger from Covid-19 as much as possible in the next 60 days, as infection rates continue to climb across the city and region. Read More
Read MoreHere’s why this CEO picked Durham over Boston for an 880-job expansion
A Durham company made a decision to stay local for a nearly 900-job expansion, after considering but ultimately rejecting Massachusetts. Read More
Read MoreFed lowers loan size to attract more small businesses to Main Street Lending Program. Again.
The Federal Reserve has changed the loan terms several times since the program debuted in March. Read More
Read MoreDockwa parent company pulls in $14.2M to bring the outdoors online
The Wanderlust Group’s Series B round will be used, in part, to launch a new platform aimed at RV park managers. Read More
Read MoreDeveloper makes another play at Downtown Crossing tower
Midwood Investment and Development has again proposed an office and retail tower at the corner of Washington and Bromfield streets. Read More
Read MoreForm D Friday: Fledgling data, dental software startups raise funds
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More
Read MoreWatertown biotech SQZ starts trading after $71M IPO
A decade ago, Armon Sharei stumbled across a simple method of getting things inside cells to create treatments for disease. Today, the company he co-founded and now leads as CEO is set to start trading on the New York Stock Exchange. Read More
Read More